Your browser doesn't support javascript.
loading
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
Strati, Paolo; Chihara, Dai; Oki, Yasuhiro; Fayad, Luis E; Fowler, Nathan; Nastoupil, Loretta; Romaguera, Jorge E; Samaniego, Felipe; Garg, Naveen; Feng, Lei; Wesson, Emily T; Ruben, Charnelle E; Stafford, Mildred D; Nieto, Yago; Khouri, Issa F; Hosing, Chitra; Horowitz, Sandra B; Kamble, Rammurti T-; Fanale, Michelle A.
Afiliación
  • Strati P; Division of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA.
  • Chihara D; Department of Internal Medicine, University of New Mexico, Albuquerque, NM, USA.
  • Oki Y; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Fayad LE; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Fowler N; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Nastoupil L; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Romaguera JE; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Samaniego F; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Garg N; Department of Diagnostic Radiology, MD Anderson Cancer Center, Houston, TX, USA.
  • Feng L; Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA.
  • Wesson ET; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Ruben CE; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Stafford MD; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Nieto Y; Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX, USA.
  • Khouri IF; Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX, USA.
  • Hosing C; Department of Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX, USA.
  • Horowitz SB; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
  • Kamble RT; Department of Hematology-Oncology, Baylor College of Medicine and Houston Methodist Hospital, TX, USA.
  • Fanale MA; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA mfanale@mdanderson.org.
Haematologica ; 103(9): e416-e418, 2018 09.
Article en En | MEDLINE | ID: mdl-29622656
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico Límite: Humans Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Células T Periférico Límite: Humans Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos